Artios Pharma
Alessandro Galbiati is currently the Biology Lead at Nerviano Medical Sciences, part of the NMS Group, since September 2024, coordinating preclinical activities for clinical programs and discovery projects while engaging with multifunctional teams for strategic decision-making. Previously, Alessandro served as Principal Scientist and Senior Scientist II at Artios from March 2021 to August 2024, focusing on cell-based assay development and screening. Prior roles include Senior Research Scientist at AstraZeneca from July 2018 to March 2021, investigating mechanisms of action, biomarker validation, and discovery within the Oncology Department. Alessandro's academic background includes a PhD in Molecular Biology from Università degli Studi di Milano, along with a Master of Science in Industrial Biotechnology and a Bachelor of Science in Biotechnology from Università degli Studi di Milano-Bicocca.
This person is not in any teams
This person is not in any offices
Artios Pharma
2 followers
Artios Pharma is a company focused on developing novel cancer treatments targeting the DNA Damage Response #DDR